BackMaravai LifeSciences Holdings Overview

Maravai LifeSciences Holdings Minority Interest

Maravai LifeSciences Holdings's minority interest is $150M.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$150.97M
↓ 25.31% YoYΔ $-51.16M vs prior year quarter

Peer trimmed avg / median

Loading

Maravai LifeSciences Holdings Minority Interest History

Loading

Maravai LifeSciences Holdings vs. peers: Minority Interest Comparison

Loading

Maravai LifeSciences Holdings Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Maravai LifeSciences Holdings (MRVI) FAQ

The latest minority interest for MRVI is $150M as of June 2026. That compares with $200M in the prior-year period — down 25.3% year over year. Investors often review this figure alongside Maravai LifeSciences Holdings's historical trend and sector peers before judging valuation or financial health.

Over the past year, MRVI's minority interest moved from $200M to $150M — a 25.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Maravai LifeSciences Holdings's operating scale or balance-sheet position.

A minority interest figure of $150M for MRVI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MRVI's minority interest ($150M), review year-over-year change from $200M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Maravai LifeSciences Holdings's minority interest against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.